Agrinews24 কৃষির সাথে, কৃষকের পাশে
International Desk : Vaxxinova has officially acquired the Avishield® poultry vaccine portfolio from Dechra Pharmaceuticals Limited, along with Dechra’s poultry vaccine research and development team based in Zagreb, Croatia.
This strategic acquisition enables Vaxxinova to expand its global footprint by adding a complete range of live vaccines for Infectious Bronchitis (IB), Gumboro Disease (IBD), and Newcastle Disease (ND) to its offerings. It also provides direct access to the European poultry vaccine market and reinforces the company’s presence in international markets.
Victor van Solinge, CEO of Vaxxinova, stated, “The addition of the Avishield® portfolio significantly strengthens our position in the poultry vaccine market and complements our existing VAXXON® range. We are excited to welcome the Zagreb R&D team, whose expertise will be key to advancing our pipeline. This acquisition highlights our long-term commitment to the poultry industry.”
Both companies have agreed on a smooth transition plan to ensure uninterrupted service and business continuity. Vaxxinova expressed confidence that this move will bring new opportunities to its partners, customers, and the broader animal health community.
